Regulus Therapeutics Soars 90% On Hepatitis C Treatment News By: Benzinga via Benzinga October 22, 2014 at 10:39 AM EDT Regulus Therapeutics Inc(NASDAQ: RGLS) announced a breakthrough Wednesday in its hepatitis C treatment, which sent the stock ... Read More >> Related Stocks: Regulus Therapeutics